In Vitro Safety Assessment of Whey Hydrolysates

Antibody mediated allergy to Cow's milk can form a major threat to the infant's health. Infants with this type of allergy cannot consume normal milk from cow origin. Cow’s milk-derived whey hydrolysates are nutritional substitutes for children with this type of allergy. These hydrolysates can be regarded as degraded proteins of which the fragments will no longer to be recognized by the immune system of the allergic child. Cow's milk (or more specifically whey) hyrolyses therefore, will not trigger an allergic reaction. For the safety of the infant it is important to assess any residual allergenicity of the hydrolyses, before using these in infant food.

Workshop “Access to 3Rs” at World Congress Alternatives great success!

August 28th, Prague The SL!M consortium organised a workshop at the 9th World Congress on Alternatives And Animal Use in the Life Sciences. The workshop focussed on the feasibility to launch an independent 3R index to benchmark companies and insititutions on 3R policies. About 60 participants of

SL!M Interview: Minder proefdieren? Meer samenwerking

Het begon drie jaar geleden met acht spaarvarkens, en mondde uit in mondiale aandacht: het project Sneller van Innovatie naar Mens (SLiM), opgezet om de implementatie van alternatieven voor dierproeven te versnellen en daarmee innovatie aan te jagen. In nauwe samenwerking tussen onderzoekers, het bedrijfsleven en overheidsinstellingen zoals RIVM en CBG. Alleen zo bereik je resultaten...

SIA RAAK Award movie online!

Check out this new video on the SIA RAAK-PRO project 'NAT-TEST'. The movie provides back ground on the project, the collaboration with partners and our research group. This movie has been produced by Regieorgaan Stichting Innovatie Alliantie who awarded our RAAK PRO 'NAT-TEST' project with the RAAK Award 2013.

SLiM project final symposium report

The SLiM project was concluded with a symposium on January 16th 2014. Over 100 representatives from industry, regulatory bodies, knowledge institutions and research & academic organizations were present during the presentations on the progress made in the SLiM project over the past three years. The full report on the symposium can be viewed and downloaded in pdf in this article.

Barriers and drivers of regulatory acceptance and use of 3R methods

Marie-Jean Schiffelers, PhD candidate at the Utrecht University School of Governance (USBO) distilled the most important drivers and barriers that act upon regulatory acceptance of 3R methods. The conclusions have been summarized in a workshop report, published as an article in Regulatory Toxicology and Pharmacology.